Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc > House Positions for Willow Biosciences - February 8, 2021

<< Previous

Bullboard Posts

Next >>

Comment by Beluga2020on Feb 08, 2021 5:17pm

100 Views

Post# 32507585

RE:House Positions for Willow Biosciences - February 8, 2021

The short positions report is somewhat useful, but can you explain what the reader is supposed to learn from these house positions? I don't get it and this report is published on the board almost everyday...thanks

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”